Polymorphism of brain derived neurotrophic factor influences β amyloid load in cognitively intact apolipoprotein E ε4 carriers.
about
Potential therapeutic effects of neurotrophins for acute and chronic neurological diseasesAPOE Genotype Effects on Intrinsic Brain Network Connectivity in Patients with Amnestic Mild Cognitive Impairment.Reproducibility and robustness of graph measures of the associative-semantic networkTrkB reduction exacerbates Alzheimer's disease-like signaling aberrations and memory deficits without affecting β-amyloidosis in 5XFAD mice.Diagnostic value of cerebrospinal fluid Aβ ratios in preclinical Alzheimer's diseaseFunctional Changes in the Language Network in Response to Increased Amyloid β Deposition in Cognitively Intact Older Adults.Imaging β-amyloid using [(18)F]flutemetamol positron emission tomography: from dosimetry to clinical diagnosis.A comparison of five partial volume correction methods for Tau and Amyloid PET imaging with [18F]THK5351 and [11C]PIB.Clinical and Environmental Correlates of Serum BDNF: A Descriptive Study with Plausible Implications for AD Research.The relationship between amyloid deposition, neurodegeneration, and cognitive decline in dementia.BDNF Val66Met predicts cognitive decline in the Wisconsin Registry for Alzheimer's Prevention.Regional vulnerability in Alzheimer's: The role of cell-autonomous and transneuronal processes.Executive function performance and change in aging is predicted by apolipoprotein E, intensified by catechol-O-methyltransferase and brain-derived neurotrophic factor, and moderated by age and lifestyle.Amyloid imaging in cognitively normal older adults: comparison between (18)F-flutemetamol and (11)C-Pittsburgh compound B.Val66Met Polymorphism and Gamma Band Disruption in Resting State Brain Functional Connectivity: A Magnetoencephalography Study in Cognitively Intact Older Females
P2860
Q26827281-0A6F662C-E288-4B2D-ABEF-C8BAB383289DQ33671934-A0C69F9D-DAD7-41C3-9633-A71AEB8783B3Q35513926-BF0C4F10-8320-4C94-AC50-C4D7542A9024Q35753185-4FD3781F-CB9D-42D1-8B5C-18102171EE94Q36383749-346F366C-DD4F-4496-8BDA-CF84D25F78E0Q38419997-6395C527-9DA2-4EDC-80FB-CA598FE91C97Q38600277-87750E9C-5F2C-4234-8BA8-9ED079D96026Q38714558-9DE7A1CF-FCE5-46BC-94B3-512BF0F1DC88Q38761126-483891C6-F8C1-4AE1-AB24-EFBF9814E55BQ39128635-D48C4807-DC5D-440A-A646-32C028E7D00AQ46093334-AFAC1C55-E0D3-4AA8-835B-0570083EB85DQ47567770-176A2397-6AD4-442C-BC10-8F1A40DA169AQ47815420-206DEA0F-CF16-47A7-A41A-BA8529C43368Q48759194-6E6EE3BE-602B-432C-9712-47738AD04689Q58586784-B166CF51-5F3C-46AB-9D0B-61443DCB4E33
P2860
Polymorphism of brain derived neurotrophic factor influences β amyloid load in cognitively intact apolipoprotein E ε4 carriers.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 April 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Polymorphism of brain derived ...... apolipoprotein E ε4 carriers.
@en
Polymorphism of brain derived ...... apolipoprotein E ε4 carriers.
@nl
type
label
Polymorphism of brain derived ...... apolipoprotein E ε4 carriers.
@en
Polymorphism of brain derived ...... apolipoprotein E ε4 carriers.
@nl
prefLabel
Polymorphism of brain derived ...... apolipoprotein E ε4 carriers.
@en
Polymorphism of brain derived ...... apolipoprotein E ε4 carriers.
@nl
P2093
P2860
P50
P1433
P1476
Polymorphism of brain derived ...... apolipoprotein E ε4 carriers.
@en
P2093
An-Sofie De Weer
Karolien Bettens
Katarzyna Adamczuk
Koen Van Laere
Mathieu Vandenbulcke
Natalie Nelissen
P2860
P304
P356
10.1016/J.NICL.2013.04.001
P50
P577
2013-04-11T00:00:00Z